Asbestos dalam paru-paru
Huw D. Roach, FRCR ● GarethJ. Davies, FRCR ● Richard
Attanoos, MRCPath ● Michael Crane, FRCR ● Haydn Adams, FRCR ● Siaˆn Phillips,
FRCR
Asbestos menimbulkan penyakit pleural effusion dan pleural plaques yang berujung pada tumor mesothelioma. Pleural effusions merupakan
cairan nanah berdarah yang ddapat didiagnosa menggunakan radiografi pada
dinding dada secara posterolateral antara rusuk ketujuh-kedelapan.
Chrysotile merupakan
komponen asbestos yang banyak terdapat dalam semen, bahan perekat, dan plastic kekerasan
tinggi. Bahaya asbestos ialah menghirup
serat fiber yang terkandung didalamnya. Ketika Chrysotile terhirup, maka
membentuk cairan mudah larut yang mengkontaminasi cairan tubuh.
Ada kriteria
menentukan apakah sesoerang telah keracunan asbestos.
Figure 1. foto radiografi Posteroanterior pasien dengan pleural effusion (tanda panah).
Benign Pleural Disease
Pleural disease merupakan penyakit paling terkait dengan
asbestos. Namun, Pleurae dianggap lebih sensitive
ke asbestos daripada parenkima
paru. Pleural disease dapat muncul
sebagai pleural effusion,dan plaques.
Pleural Effusion
Benign pleural effusions dianggap fenomena paling cepat dari
kondisi menderita secara pleural.
Malignant Mesothelioma
Malignant mesothelioma terjadi ketika pleura menyebar ke tunica vaginalis testis. Malignant mesothelioma
memiliki rasio risiko 1:100:500 dan bila membesar akan mengakibatkan gangguan
dinding dada.
Conclusion
Perlu menyadari karakteristik asbestos agar tidak menimbulkan malignant mesothelioma. Utuk itu perlu
diadakan pemantauan.
References
1. Peacock
C, Copley SJ, Hansell DM. Asbestos-related benign pleural disease. Clin Radiol
2000; 55:422–432.
2. Peto J,
Hodgson JT, Matthews FE, Jones JR. Con-tinuing increase in mesothelioma
mortality in Brit-ain. Lancet 1995; 345:535–539.
3. Consensus
Report. International expert meeting on new advances in the radiology and
screening of asbestos-related diseases. Scand J Work Environ Health 2000;
26:449–454.
4. Report by
the Industrial Injuries Advisory Council in accordance with Section 171 of the
Social Security Administration Act 1992: asbestos related diseases. London,
United Kingdom: Her Majesty’s Stationery Office, 1996.
5. International
Labour Office: Guidelines for the use of ILO international classification of
radiographs of pneumoconiosis, 1980 ed. Geneva, Switzerland: International
Labour Office, 1980.
6. Shipley
RT. The 1980 ILO Classification of the radiographs of the pneumoconioses.
Radiol Clin North Am 1992; 30:1135–1145.
7. Huuskonen
O, Kivisaari L, Zitting A, et al. High-resolution computed tomography
classification of lung fibrosis for patients with asbestos-related dis-ease.
Scand J Work Environ Health 2001; 27:106– 112.
8. Suganuma
N, Kusaka Y, Hosoda Y, et al. The Japanese classification of computed
tomography for pneumoconioses with standard films: comparison with the ILO
International Classification of radiographs for pneumoconioses. J Occup Health
2001; 43:24–31.
9. Aberle
DR, Balmes JR. Computed tomography of asbestos-related pulmonary parenchymal
and pleural diseases. Clin Chest Med 1991; 12:115– 131.
10. Eisenstadt
HB. Asbestos pleurisy. Dis Chest 1964; 46:78–81.
11. Epler GR,
McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural
effusion in a working population. JAMA 1982; 247:617– 622.
12. Kim KI, Kim
CW, Lee MK, et al. Imaging of oc-cupational lung disease. RadioGraphics 2001;
21: 1371–1391.
13. Hillerdal
G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur
J Resp Dis 1987; 71:113–121.
14. Fletcher
DE, Edge JR. The radiological changes in pulmonary and pleural asbestosis. Clin
Radiol 1970; 21:355–365.
15. Hu H,
Beckett L, Kelsey K, Christiani D. The left-sided predominance of
asbestos-related pleural disease. Am Rev Respir Dis 1993; 148:981– 984.
16. Gallego JC.
Absence of left-sided predominance in asbestos-related pleural plaques: a CT
study. Chest 1998; 113:1034–1036.
17. Sebastien
P, Janson X, Gaudichet A, Hirsch A, Bignon J. Asbestos retention in human
respiratory tissues: comparative measurements in lung parenchyma and in
parietal pleura. IARC Sci Publica 1980;237–246.
18. Hillerdal
G. The pathogenesis of pleural plaques and pulmonary asbestosis: possibilities
and impos-sibilities. Eur J Resp Dis 1980; 61:129–138.
19. Al Jarad N,
Poulakis N, Pearson MC, Rubens MB, Rudd RM. Assessment of asbestos-induced
pleural disease by computed tomography: correlation with chest radiograph and
lung function. Respir Med 1991; 85:203–208.
20. Aberle DR,
Gamsu G, Ray CS, Feuerstein IM. Asbestos-related pleural and parenchymal
fibrosis: detection with high-resolution CT. Radiology 1988; 166:729–734.
21. Friedman
AC, Fiel SB, Fisher MS, Radecki PD, Lev-Toaff AS, Caroline DF. Asbestos-related
pleural disease and asbestosis: a comparison of CT and chest radiography. AJR
Am J Roentgenol 1988; 150:269–275.
22. Stephens M,
Gibbs AR, Pooley FD, Wagner JC. Asbestos induced diffuse pleural fibrosis:
pathol-ogy and mineralogy. Thorax 1987; 42:583–588.
